Table 5

Gaps in current evidence

SettingTrials/studies neededMain questions to be addressed
Acute heart failureAdditional randomized trials assessing whether LUS can improve the diagnosis and characterization of patients with AHF beyond traditional approaches.
  • Can the use of LUS facilitate the classification of AHF phenotypes that may benefit from specific therapeutic interventions?

  • Can LUS imaging be used to improve management decisions in patients with AHF, e.g. hospital admission vs. early discharge from the Emergency Department?

  • Is the use of LUS imaging effective and safe as part of a strategy to improve congestion relief in AHF, including intensification/de-intensification of diuretic therapy?

  • Can the use of LUS improve post-discharge outcomes in patients with AHF?

Chronic heart failureDevelopment and validation of diagnostic protocols assessing the utility of LUS at rest or during exercise in the diagnosis of HFpEF.
  • Can the use of LUS improve the clinical course of patients with chronic HF (HFrEF and/or HFpEF)?

  • Can the use of LUS facilitate the identification of subsets of patients with chronic HF that can benefit from specific therapeutic interventions?

  • Is the use of LUS in the management of patients with chronic HF cost-effective?

  • Can the use of LUS improve the clinical course of specific HF phenotypes (myocarditis, cardiotoxicity, inherited cardiomyopathies, post-partum cardiomyopathy, and cardiac amyloidosis)?

Acute coronary syndromesAdditional randomized trials assessing whether LUS can improve the diagnosis of the aetiology of chest pain beyond traditional approaches.
  • Can the use of LUS facilitate the identification of subsets of patients with ACS that may benefit from specific therapeutic interventions?

SettingTrials/studies neededMain questions to be addressed
Acute heart failureAdditional randomized trials assessing whether LUS can improve the diagnosis and characterization of patients with AHF beyond traditional approaches.
  • Can the use of LUS facilitate the classification of AHF phenotypes that may benefit from specific therapeutic interventions?

  • Can LUS imaging be used to improve management decisions in patients with AHF, e.g. hospital admission vs. early discharge from the Emergency Department?

  • Is the use of LUS imaging effective and safe as part of a strategy to improve congestion relief in AHF, including intensification/de-intensification of diuretic therapy?

  • Can the use of LUS improve post-discharge outcomes in patients with AHF?

Chronic heart failureDevelopment and validation of diagnostic protocols assessing the utility of LUS at rest or during exercise in the diagnosis of HFpEF.
  • Can the use of LUS improve the clinical course of patients with chronic HF (HFrEF and/or HFpEF)?

  • Can the use of LUS facilitate the identification of subsets of patients with chronic HF that can benefit from specific therapeutic interventions?

  • Is the use of LUS in the management of patients with chronic HF cost-effective?

  • Can the use of LUS improve the clinical course of specific HF phenotypes (myocarditis, cardiotoxicity, inherited cardiomyopathies, post-partum cardiomyopathy, and cardiac amyloidosis)?

Acute coronary syndromesAdditional randomized trials assessing whether LUS can improve the diagnosis of the aetiology of chest pain beyond traditional approaches.
  • Can the use of LUS facilitate the identification of subsets of patients with ACS that may benefit from specific therapeutic interventions?

AHF, acute heart failure; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; HFpEF, heart failure with preserved ejection fraction; LUS, lung ultrasound.

Table 5

Gaps in current evidence

SettingTrials/studies neededMain questions to be addressed
Acute heart failureAdditional randomized trials assessing whether LUS can improve the diagnosis and characterization of patients with AHF beyond traditional approaches.
  • Can the use of LUS facilitate the classification of AHF phenotypes that may benefit from specific therapeutic interventions?

  • Can LUS imaging be used to improve management decisions in patients with AHF, e.g. hospital admission vs. early discharge from the Emergency Department?

  • Is the use of LUS imaging effective and safe as part of a strategy to improve congestion relief in AHF, including intensification/de-intensification of diuretic therapy?

  • Can the use of LUS improve post-discharge outcomes in patients with AHF?

Chronic heart failureDevelopment and validation of diagnostic protocols assessing the utility of LUS at rest or during exercise in the diagnosis of HFpEF.
  • Can the use of LUS improve the clinical course of patients with chronic HF (HFrEF and/or HFpEF)?

  • Can the use of LUS facilitate the identification of subsets of patients with chronic HF that can benefit from specific therapeutic interventions?

  • Is the use of LUS in the management of patients with chronic HF cost-effective?

  • Can the use of LUS improve the clinical course of specific HF phenotypes (myocarditis, cardiotoxicity, inherited cardiomyopathies, post-partum cardiomyopathy, and cardiac amyloidosis)?

Acute coronary syndromesAdditional randomized trials assessing whether LUS can improve the diagnosis of the aetiology of chest pain beyond traditional approaches.
  • Can the use of LUS facilitate the identification of subsets of patients with ACS that may benefit from specific therapeutic interventions?

SettingTrials/studies neededMain questions to be addressed
Acute heart failureAdditional randomized trials assessing whether LUS can improve the diagnosis and characterization of patients with AHF beyond traditional approaches.
  • Can the use of LUS facilitate the classification of AHF phenotypes that may benefit from specific therapeutic interventions?

  • Can LUS imaging be used to improve management decisions in patients with AHF, e.g. hospital admission vs. early discharge from the Emergency Department?

  • Is the use of LUS imaging effective and safe as part of a strategy to improve congestion relief in AHF, including intensification/de-intensification of diuretic therapy?

  • Can the use of LUS improve post-discharge outcomes in patients with AHF?

Chronic heart failureDevelopment and validation of diagnostic protocols assessing the utility of LUS at rest or during exercise in the diagnosis of HFpEF.
  • Can the use of LUS improve the clinical course of patients with chronic HF (HFrEF and/or HFpEF)?

  • Can the use of LUS facilitate the identification of subsets of patients with chronic HF that can benefit from specific therapeutic interventions?

  • Is the use of LUS in the management of patients with chronic HF cost-effective?

  • Can the use of LUS improve the clinical course of specific HF phenotypes (myocarditis, cardiotoxicity, inherited cardiomyopathies, post-partum cardiomyopathy, and cardiac amyloidosis)?

Acute coronary syndromesAdditional randomized trials assessing whether LUS can improve the diagnosis of the aetiology of chest pain beyond traditional approaches.
  • Can the use of LUS facilitate the identification of subsets of patients with ACS that may benefit from specific therapeutic interventions?

AHF, acute heart failure; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; HFpEF, heart failure with preserved ejection fraction; LUS, lung ultrasound.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close